NCT03541148View on ClinicalTrials.gov

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 16, 2014

Primary Completion Date

April 13, 2016

Study Completion Date

April 13, 2018

Conditions
Cutaneous Melanoma, Stage IIMalignant Cutaneous MelanomaCutaneous Melanoma, Stage III
Interventions
DIETARY_SUPPLEMENT

Oncoxin-Viusid

Oncoxin-Viusid supplement before/during/after standard surgical and adjuvant treatment or chemotherapy.

Trial Locations (1)

10600

Manuel Fajardo Clinical Surgical University Hospital, La Habana

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT03541148 - Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma | Biotech Hunter | Biotech Hunter